BrainFectIN -In vivo Transfection Reagent
BrainFectIN™ enables nucleic acids delivery into central nervous system of small animals.
Major difficulties with gene delivery in the central nervous system is the weakness of standard non-viral gene carriers and the limitations associated to the use of viral particles (time-consuming and requires additional saftey precautions). Unlike these methods, BrainFectIN™ is an original non-viral formulation that allows safe, easy and efficient nucleic acids delivery into central nervous system of small animals.
This transfection reagent allows transfection of neural cells in specific brain following stereotaxic injection, with low immunogenicity and rapid and long-term transgene expression.
BrainFectIN™ has been designed by our R&D team to meet in vivo grade quality (reagents performed under high manufacturing and quality standards and tested by strict quality controls).
BrainFectIN™ main advantages:
Targeted process (stereotaxic injection)
Good transfection efficiency
Reduction of the injection volume
Reduction of the DNA doses
Minimized toxicity
Low immunogenicity
Rapid and long-term transgene expression
Sizes :
100 µL of BrainFectIN™ / 20-30 injections
250 µLof BrainFectIN™ / 40-60 injections
500 µLof BrainFectIN™ / 80-120 injections
Major difficulties with gene delivery in the central nervous system is the weakness of standard non-viral gene carriers and the limitations associated to the use of viral particles (time-consuming and requires additional saftey precautions). Unlike these methods, BrainFectIN™ is an original non-viral formulation that allows safe, easy and efficient nucleic acids delivery into central nervous system of small animals.
This transfection reagent allows transfection of neural cells in specific brain following stereotaxic injection, with low immunogenicity and rapid and long-term transgene expression.
BrainFectIN™ has been designed by our R&D team to meet in vivo grade quality (reagents performed under high manufacturing and quality standards and tested by strict quality controls).
BrainFectIN™ main advantages:
Targeted process (stereotaxic injection)
Good transfection efficiency
Reduction of the injection volume
Reduction of the DNA doses
Minimized toxicity
Low immunogenicity
Rapid and long-term transgene expression
Sizes :
100 µL of BrainFectIN™ / 20-30 injections
250 µLof BrainFectIN™ / 40-60 injections
500 µLof BrainFectIN™ / 80-120 injections
| Supplier | Amerigo Scientific |
|---|---|
| Product # | IV-BF30100 |
| Pricing | 100 µL; 250 µL; 500 µL, Inquire |